Marinus Pharmaceuticals, Inc.
GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS

Last updated:

Abstract:

This invention relates to methods for treating status epilepticus by administering to the subject in need thereof an intravenous bolus of ganaxolone and a continuous intravenous infusion of a neurosteroid. The method provides SE suppression and continued suppression of SE.

Status:
Application
Type:

Utility

Filling date:

26 Feb 2021

Issue date:

24 Jun 2021